LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Evelo Biosciences

Similar companies to Evelo Biosciences

Evelo Biosciences Tech Stack

Evelo Biosciences uses 8 technology products and services including Cookie Notice, React, Swiper, and more. Explore Evelo Biosciences's tech stack below.

  • Cookie Notice
    Cookie Compliance
  • React
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Webpack
    Miscellaneous
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Drupal Multisite
    Web Hosting

Media & News

Evelo Biosciences's Email Address Formats

Evelo Biosciences uses at least 1 format(s):
Evelo Biosciences Email FormatsExamplePercentage
FLast@evelobio.comJDoe@evelobio.com
65%
First@evelobio.comJohn@evelobio.com
20%
Last@evelobio.comDoe@evelobio.com
14%
First.Last@evelobio.comJohn.Doe@evelobio.com
1%

Frequently Asked Questions

Where is Evelo Biosciences's headquarters located?

Minus sign iconPlus sign icon
Evelo Biosciences's main headquarters is located at One Kendall Square, Building 600/700 Suite 7-201 Cambridge, MA 02139 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Evelo Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Evelo Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evelo Biosciences's stock symbol?

Minus sign iconPlus sign icon
Evelo Biosciences is a publicly traded company; the company's stock symbol is EVLO.

What is Evelo Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Evelo Biosciences's official website is evelobio.com and has social profiles on LinkedIn.

How much revenue does Evelo Biosciences generate?

Minus sign iconPlus sign icon
As of July 2024, Evelo Biosciences's annual revenue reached $35M.

What is Evelo Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Evelo Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evelo Biosciences have currently?

Minus sign iconPlus sign icon
As of July 2024, Evelo Biosciences has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. G.Chief Technology & Quality Officer: C. Z.Chief Medical Officer: D. M.. Explore Evelo Biosciences's employee directory with LeadIQ.

What industry does Evelo Biosciences belong to?

Minus sign iconPlus sign icon
Evelo Biosciences operates in the Biotechnology Research industry.

What technology does Evelo Biosciences use?

Minus sign iconPlus sign icon
Evelo Biosciences's tech stack includes Cookie NoticeReactSwiperMicrosoftWebpackHSTSX-XSS-ProtectionDrupal Multisite.

What is Evelo Biosciences's email format?

Minus sign iconPlus sign icon
Evelo Biosciences's email format typically follows the pattern of . Find more Evelo Biosciences email formats with LeadIQ.

How much funding has Evelo Biosciences raised to date?

Minus sign iconPlus sign icon
As of July 2024, Evelo Biosciences has raised $26M in funding. The last funding round occurred on Jul 10, 2023 for $26M.

When was Evelo Biosciences founded?

Minus sign iconPlus sign icon
Evelo Biosciences was founded in 2015.
Evelo Biosciences

Evelo Biosciences

Biotechnology ResearchMassachusetts, United States51-200 Employees

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.

Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases and EDP1908 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.

Section iconCompany Overview

Headquarters
One Kendall Square, Building 600/700 Suite 7-201 Cambridge, MA 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EVLO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $26M

    Evelo Biosciences has raised a total of $26M of funding over 8 rounds. Their latest funding round was raised on Jul 10, 2023 in the amount of $26M.

  • $10M$50M

    Evelo Biosciences's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $26M

    Evelo Biosciences has raised a total of $26M of funding over 8 rounds. Their latest funding round was raised on Jul 10, 2023 in the amount of $26M.

  • $10M$50M

    Evelo Biosciences's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.